Abstract:Background Sphingolipids produce pleiotropic signaling pathways, and participate in the pathological mechanism of hepatocyte apoptosis and necrosis during liver injury. However, the role of glucosylceramide synthase (GCS)–key enzyme that catalyzes the first glycosylation step, in liver injury is still vague. Methods All experiments were conducted using 7–9-week-old pathogen-free male C57BL/6 mice. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were detected in murine models of liver disease, in addition to histological characterization of liver injuries. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the relative expression of the GCS, matrix metallopeptidase-1 (MMP-1), and tissue inhibitor of metalloproteinase-1 (TIMP-1) genes. The GCS was observed through a fluorescence microscope, and the flow cytometry was used to detect hepatocyte apoptosis. The concentrations of serum IL-4, IL-6, and IL-10 were measured using enzyme-linked immune-sorbent assay (ELISA) kit. MMP-1 and TIMP-1 protein expression was measured via western blot (WB) analysis. Results Con A is often used as a mitogen to activate T lymphocytes and promote mitosis. A single dose of Con A injected intravenously will cause a rapid increase of ALT and AST, which is accompanied by the release of cytokines that cause injury and necrosis of hepatocytes. In this study, we successfully induced acute immune hepatitis in mice by Con A. Con A administration resulted in GCS upregulation in liver tissues. Moreover, the mice in the Con A group had significantly higher levels of ALT, AST, IL-4, IL-6, IL-10 and increased hepatocyte apoptosis than the control group. In contrast, all of the aforementioned genes were significantly downregulated after the administration of a GCS siRNA or Genz-123346 ( i.e. , a glucosylceramide synthase inhibitor) to inhibit the GCS gene. Additionally, the histopathological changes observed herein were consistent with our ALT, AST, IL-4, IL-6, and IL-10 expression results. However, unlike this, hepatocyte apoptosis has been further increased on the basis of the Con A group. Moreover, our qRT-PCR and WB results indicated that the expression of MMP-1 in the Con A group was significantly lower than that in the control group, whereas TIMP-1 exhibited the opposite trend. Conversely, MMP-1 expression in the GCS siRNA and Genz-123346 groups was higher than that in the Con A group, whereas TIMP-1 expression was lower. Conclusions GCS inhibition reduces Con A-induced immune-mediated liver injury in mice, which may be due to the involvement of GCS in the hepatocyte repair process after injury.

Chitinase 3-Like-1 Promotes Intrahepatic Activation of Coagulation Through Induction of Tissue Factor in Mice.

Chitinase 3‐like 1 deficiency ameliorates liver fibrosis by promoting hepatic macrophage apoptosis

Mechanisms of concanavalin A-induced cytokine synthesis by hepatic stellate cells: Distinct roles of interferon regulatory factor-1 in liver injury

Role of Chitinase 3-Like 1 Protein in the Pathogenesis of Hepatic Insulin Resistance in Nonalcoholic Fatty Liver Disease

Chitinase 3-like-1 contributes to acetaminophen-induced liver injury by promoting hepatic platelet recruitment

CHI3L1 Alleviate Acute Liver Injury by Inhibiting Th1 Cells Differentiation Through STAT3 Signaling Pathway.

The mechanism of how anti-IL-18 prevents concanavalin-A-induced hepatic fibrosis on a mouse model.

The Protective Effect of Intrasplenic Transplantation of Ad-IL-18BP/IL-4 Gene-Modified Fetal Hepatocytes on ConA-induced Hepatitis in Mice.

Caspase Inhibition Reduces Hepatic Tissue Factor-Driven Coagulation In Vitro and In Vivo

The molecular mechanism of acute liver injury and inflammatory response induced by Concanavalin A

CD8+ T cell/IL-33/ILC2 axis exacerbates the liver injury in Con A-induced hepatitis in T cell-transferred Rag2-deficient mice

CX3CR1 deficiency exacerbates immune-mediated hepatitis by increasing NF-B-mediated cytokine production in macrophage and T cell

Tissue Inhibitor of Metalloproteinase 1 (TIMP-1) Deficiency Exacerbates Carbon Tetrachloride-Induced Liver Injury and Fibrosis in Mice: Involvement of Hepatocyte STAT3 in TIMP-1 Production

Glucosylceramide synthase regulates hepatocyte repair after concanavalin A-induced immune-mediated liver injury

Kupffer Cells Contribute to Concanavalin A-induced Hepatic Injury Through a Th1 but Not Th17 Type Response-Dependent Pathway in Mice

Critical role of interleukin-17/interleukin-17 receptor axis in mediating Con A-induced hepatitis.

The Protective Role of IL-36/IL-36R Signal in Con A-Induced Acute Hepatitis

Zingerone attenuates concanavalin A-induced acute liver injury by restricting inflammatory responses

Mesenchymal Stem Cells Alleviate Experimental Immune-Mediated Liver Injury Via Chitinase 3-Like Protein 1-Mediated T Cell Suppression

High-mobility group box 1 exacerbates concanavalin A-induced hepatic injury in mice

The Role of Intracellular High-Mobility Group Box 1 in the Early Activation of Kupffer Cells and the Development of Con A-induced Acute Liver Failure